By Dr. Gernot Stuhler, Prof. Dr. Peter Walden
Read Online or Download Cancer Immune Therapy : Current and Future Strategies PDF
Best oncology books
Because the Nineteen Seventies, euthanasia has been a subject matter of continuous debate around the world. This publication offers an in depth description of the talk in addition to a serious research of the main salient facets of euthanasia perform within the Netherlands. The authors argue that euthanasia will be understood inside of a historic context as a protest opposed to scientific strength.
This new quantity brings jointly the present pondering in either research and administration of the melanoma sufferer. It offers a complete caseload as obvious by way of the oncologist. those are universal but hard real-life sufferer eventualities, which the authors get to the bottom of via drawing at the most up-to-date released literature.
Melanoma stem cells have initially been pointed out in leukemia and later in numerous strong tumor kinds. they've got very diversified homes from the majority of the tumor as they divide even more slowly and feature very effective drug resistance mechanisms. present remedies may possibly principally spare melanoma stem cells.
- Target Discovery and Validation Reviews and Protocols: Volume 2: Emerging Molecular Targets and Treatment Options
- Multiple Primary Malignancies
- Atlas of Minimally Invasive Surgery in Esophageal Carcinoma
- Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
- Cancer Gene Profiling: Methods and Protocols
- Sexual Function in the Prostate Cancer Patient
Extra info for Cancer Immune Therapy : Current and Future Strategies
341 ±, RCC-derived 100 ±, tumor-associated 109 ±, tumor-derived 105 gastro-intestinal cancer, clinical trials 191 GCV see gancyclovir GD2 see disialoganglioside gene expression 10, 18 f. ±, MHC antigens 63 f. ±, underexpressed genes 23 ±, see also expression genetic linkages to autoimmune diseases 215 f. , 258±263 gp100 antigen 334 f. graft-versus-host (GvH) reactions 299±307 graft-versus-host disease (GvHD) 299±307 ±, leukemia 361 f. graft-versus-leukemia (GvL) effect 301 ff. 399 400 Index graft-versus-tumor (GvT) effect 299, 301 granules, Birbeck 180 granulocyte macrophage colony stimulating factor (GM-CSF) ±, dendritic cells 184 ±, effects of IL-10 165 granulocytes, FasL 112 f.
The makings of a tumor rejection antigen, Immunity 11: 263±70, 1999. 18 Schultze, J. L. and Vonderheide, R. H. From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens, Trends Immunol 22: 516±23, 2001. , Robbins, P. F. and Parmiani, G. A listing of human tumor antigens recognized by T cells, Cancer Immunol Immunother 50: 3±15, 2001. , Protti, M. , Sinigaglia, F. and Hammer, J. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II, Nat Biotechnol 17: 555±561, 1999.
31 Kolquist, K. , Ellisen, L. , Counter, C. , Tan, L. , Weinberg, R. , Haber, D. A. and Gerald,W. L. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues, Nat Genet 19: 182±6, 1998. , Schmidt, J. , Langlade-Demoyen, P. and Zanetti, M. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans, Proc Natl Acad Sci USA 97: 4796±801, 2000. 33 Nair, S. , Lebkowski, J. ,Vieweg, J. and Gilboa, E. Induction of cytotoxic T lymphocyte responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells, Nat Med 6: 1011±7, 2000.
Cancer Immune Therapy : Current and Future Strategies by Dr. Gernot Stuhler, Prof. Dr. Peter Walden